PANDAS in a 23-Year-Old Male: Clinical Presentation and Diagnostic Approach
Critical Age Consideration
PANDAS diagnostic criteria explicitly require prepubertal symptom onset, making this diagnosis highly unlikely in a 23-year-old male presenting with new symptoms. 1, 2 The original PANDAS cohort demonstrated mean age of onset at 6.3 years for tics and 7.4 years for OCD, with all cases occurring in childhood. 1
If Symptoms Began in Childhood (Retrospective Diagnosis)
Cardinal Clinical Features
PANDAS presents with five essential diagnostic criteria that must all be present: 1, 2
- Abrupt, dramatic onset of obsessive-compulsive disorder (OCD) and/or tic disorder in prepubertal years 1
- Episodic, relapsing-remitting course with clear exacerbations and remissions 1
- Temporal association with Group A beta-hemolytic streptococcal (GABHS) infection, documented by positive throat culture, rapid antigen test, or elevated anti-streptolysin O (ASO) and anti-DNase B titers 3, 1
- Neurological abnormalities including choreiform movements, motor hyperactivity, or tics 1
- Psychiatric comorbidities during exacerbations: separation anxiety (86-92%), urinary urgency/frequency without infection (42-81%), sleep disruptions (71%), emotional lability, nighttime fears, and cognitive deficits 1, 2
Distinctive Urinary Symptoms
Daytime urinary urgency and frequency without dysuria, fever, or incontinence occurs in 42-81% of PANDAS cases and represents a highly characteristic feature. 3, 2 These symptoms disappear at night, and urinalysis/urine cultures are negative. 3
Diagnostic Workup
Document streptococcal infection through throat culture (rapid antigen and/or culture) and serologic testing (ASO and anti-DNase B titers). 3, 1 In the original prospective study, very high anti-DNase B titers were characteristic. 3
Rule out alternative autoimmune encephalopathies that can present with neuropsychiatric symptoms in young adults: 4
- Anti-NMDA receptor encephalitis: More common in young adults, presents with acute psychiatric symptoms, seizures, and dyskinetic movements 5
- Neuropsychiatric systemic lupus erythematosus (NPSLE): Requires comprehensive evaluation including MRI with gadolinium, CSF analysis, antiphospholipid antibodies, and exclusion of infection 6, 7
Neuropsychological Assessment
Expect relative deficits in frontostriatal network functions even after acute symptom resolution: 8
- Attentional regulation and inhibitory control difficulties 8
- Reduced processing speed and graphomotor skills 8
- Normal intellectual functioning but impaired reading/math fluency 8
- Persistent anxiety, depression, inattention, and social skills deficits requiring ongoing intervention 8
Treatment Approach (If Childhood-Onset PANDAS Confirmed)
Acute Management
Treat documented GABHS infection with amoxicillin/clavulanic acid for 10-21 days. 4 In prospectively identified cases, OCD symptoms promptly disappeared with appropriate antibiotic therapy at the sentinel episode. 3
Long-Term Prophylaxis
Administer benzathine benzylpenicillin prophylaxis for at least 5 years to prevent streptococcal reinfections and neuropsychiatric relapses. 4 This regimen, similar to acute rheumatic fever prophylaxis, resulted in improvement in 75% of PANDAS patients within 3-5 months, though 45% experienced infection-related relapses during long-term follow-up. 4
Monitoring Strategy
Obtain prospective throat cultures after treatment to distinguish true infection from GABHS carrier state. 3 Recurrence of OCD symptoms associated with documented acute GABHS infection and response to antibiotics confirms active disease rather than carrier status. 3
Critical Pitfalls
Do not diagnose PANDAS in adults with new-onset symptoms—consider anti-NMDA receptor encephalitis, NPSLE, or other autoimmune encephalopathies instead. 5, 7 The prepubertal onset criterion is fundamental to PANDAS diagnosis. 1, 2
Do not confuse PANDAS with PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)—PANS has similar presentation but lacks documented streptococcal association and may be triggered by Mycoplasma pneumoniae (42.3%) or Epstein-Barr virus (19.2%). 4 PANS patients showed improvement after 6-12 months versus 3-5 months for PANDAS. 4
Early diagnosis is essential—delayed recognition increases risk of disabling chronic neurologic sequelae. 4